A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea

You may be eligible if

• 18 years of age
• The presence of CDAD at the time of enrollment with no other likely etiology for the diarrhea
• Less than or equal to 48 hours of treatment with metronidazole, vancomycin or other antibacterial therapy specific for CDAD
• Baseline serum potassium \> 3.0 mmol (meq)/L
• Patient considered sufficiently stable clinically to likely complete a 6 week study period